For more than 15 million people, taking a 23andMe test once seemed like a good idea.  For around 80% of customers, their interaction with the company went even further—they opted to have their data used in health research.

As you may know, 23andMe collects and holds sensitive, immutable, identifiable personal information about millions of American consumers who have used the Company's genetic testing and telehealth services.

23andMe, the company whose mail-in self-testing kits became synonymous with DNA testing, is filing for bankruptcy . Anne Wojcicki, who co-founded 23andMe in 2006, is stepping down as CEO as the company tries to find a buyer amid slowing sales four years after going public.

Following the firm’s bankruptcy, researchers hope that they will be able to continue accessing the valuable data set even if it is sold to new owners.

Genetic testing service 23andMe has filed for Chapter 11 bankruptcy protection to keep the company running while reorganizing its debts.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' genetic information up for sale.

Since genetics testing firm 23andMe filed for Chapter 11 bankruptcy protection and said it would seek to sell its assets, consumer advocates have voiced co

Me, one of the first companies to provide direct-to-consumer genetic testing kits, has filed for bankruptcy. Since its founding in 2006, it has sold over 12 million DNA kits, with high-profile users including Oprah Winfrey and Warren Buffett.

Would you trust a company with your most personal data — your DNA — if it was on the brink of collapse? Millions of 23andMe customers are now facing that unsettling reality as the genetic testing company faces an uncertain future.